293 related articles for article (PubMed ID: 15353127)
1. The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
Wang G; Dombkowski A; Chuang L; Xu XX
Cell Res; 2004 Aug; 14(4):303-14. PubMed ID: 15353127
[TBL] [Abstract][Full Text] [Related]
2. The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation.
Wang G; Chuang L; Zhang X; Colton S; Dombkowski A; Reiners J; Diakiw A; Xu XS
Nucleic Acids Res; 2004; 32(7):2231-40. PubMed ID: 15107491
[TBL] [Abstract][Full Text] [Related]
3. Defining the function of XPC protein in psoralen and cisplatin-mediated DNA repair and mutagenesis.
Chen Z; Xu XS; Yang J; Wang G
Carcinogenesis; 2003 Jun; 24(6):1111-21. PubMed ID: 12807748
[TBL] [Abstract][Full Text] [Related]
4. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
[TBL] [Abstract][Full Text] [Related]
5. Association between the unfolded protein response, induced by 2-deoxyglucose, and hypersensitivity to cisplatin: a mechanistic study employing molecular genomics.
Gaddameedhi S; Chatterjee S
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S61-6. PubMed ID: 20009298
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells.
Shen YH; Chen BR; Cherng SH; Chueh PJ; Tan X; Lin YW; Lin JC; Chuang SM
Toxicol Lett; 2011 Sep; 205(3):341-50. PubMed ID: 21742020
[TBL] [Abstract][Full Text] [Related]
7. The role of p53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts.
Bhana S; Lloyd DR
Mutagenesis; 2008 Jan; 23(1):43-50. PubMed ID: 18003626
[TBL] [Abstract][Full Text] [Related]
8. XPC is essential for nucleotide excision repair of zidovudine-induced DNA damage in human hepatoma cells.
Wu Q; Beland FA; Chang CW; Fang JL
Toxicol Appl Pharmacol; 2011 Mar; 251(2):155-62. PubMed ID: 21192964
[TBL] [Abstract][Full Text] [Related]
9. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.
Gatti L; Supino R; Perego P; Pavesi R; Caserini C; Carenini N; Righetti SC; Zuco V; Zunino F
Cell Death Differ; 2002 Dec; 9(12):1352-9. PubMed ID: 12478472
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
Barckhausen C; Roos WP; Naumann SC; Kaina B
Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.
Zuco V; Zanchi C; Cassinelli G; Lanzi C; Supino R; Pisano C; Zanier R; Giordano V; Garattini E; Zunino F
Cell Death Differ; 2004 Mar; 11(3):280-9. PubMed ID: 14657960
[TBL] [Abstract][Full Text] [Related]
13. A portrait of cisplatin-induced transcriptional changes in mouse embryonic stem cells reveals a dominant p53-like response.
Kruse JJ; Svensson JP; Huigsloot M; Giphart-Gassler M; Schoonen WG; Polman JE; Jean Horbach G; van de Water B; Vrieling H
Mutat Res; 2007 Apr; 617(1-2):58-70. PubMed ID: 17327130
[TBL] [Abstract][Full Text] [Related]
14. Global gene expression changes underlying Stachybotrys chartarum toxin-induced apoptosis in murine alveolar macrophages: evidence of multiple signal transduction pathways.
Wang H; Yadav JS
Apoptosis; 2007 Mar; 12(3):535-48. PubMed ID: 17186382
[TBL] [Abstract][Full Text] [Related]
15. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
Anthoney DA; McIlwrath AJ; Gallagher WM; Edlin AR; Brown R
Cancer Res; 1996 Mar; 56(6):1374-81. PubMed ID: 8640828
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.
Zhou Y; Gwadry FG; Reinhold WC; Miller LD; Smith LH; Scherf U; Liu ET; Kohn KW; Pommier Y; Weinstein JN
Cancer Res; 2002 Mar; 62(6):1688-95. PubMed ID: 11912141
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent expression changes of early response genes to ionizing radiation in human lymphoblastoid cells.
Long XH; Zhao ZQ; He XP; Wang HP; Xu QZ; An J; Bai B; Sui JL; Zhou PK
Int J Mol Med; 2007 Apr; 19(4):607-15. PubMed ID: 17334636
[TBL] [Abstract][Full Text] [Related]
19. Activation of the transcription factor Oct-1 in response to DNA damage.
Zhao H; Jin S; Fan F; Fan W; Tong T; Zhan Q
Cancer Res; 2000 Nov; 60(22):6276-80. PubMed ID: 11103783
[TBL] [Abstract][Full Text] [Related]
20. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells.
Cheung HW; Jin DY; Ling MT; Wong YC; Wang Q; Tsao SW; Wang X
Cancer Res; 2005 Feb; 65(4):1450-8. PubMed ID: 15735033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
